Methylprednisolone Acetate (Depo-Medrol) Injection during Cataract Surgery Causing Retinal Necrosis
نویسندگان
چکیده
منابع مشابه
Depo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL
Each mL of these preparations contains: Methylprednisolone acetate..................................20 mg Polyethylene glycol 3350.....................................29.5 mg Polysorbate 80 .....................................................1.97 mg Monobasic sodium phosphate ...............................6.9 mg Dibasic sodium phosphate USP...........................1.44 mg Benzyl alcohol add...
متن کاملDEPO-MEDROL Label
Each mL of these preparations contains: Methylprednisolone acetate.............................. 20 mg Polyethylene glycol 3350....................................29.5 mg Polysorbate 80 ....................................................1.97 mg Monobasic sodium phosphate ..............................6.9 mg Dibasic sodium phosphate USP..........................1.44 mg Benzyl alcohol added as a...
متن کاملDepo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
In the US, obesity rates are increasing greatly. The Centers for Disease Control and Prevention estimates that 68.5% of Americans, including 63.9% of adult women older than 20 years, are overweight (body mass index between 25 kg/m2 and 29.9 kg/m2) or obese (body mass index >30 kg/m2). In light of this, it is not surprising that the rates of bariatric surgery have also been increasing. When cons...
متن کاملSubcutaneous depo-medroxyprogesterone acetate.
To cite: Cameron S. Journal of Family Planning and Reproductive Health Care 2013;39:75–77. INTRODUCTION Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe. As of March 2013 this product is being marketed in the UK as Sa...
متن کاملRetinal Detachment Following Cataract Surgery
The technical progress in cataract treatment led to the significant decrease of retinal detachment (RD) following surgery. Globally, the risk for RD, 4 years after cataract surgery is around 0.93%. The strategy to decrease the risk for pseudophakic RD includes: preoperative identification of the retinal lesions predisposing to RD, high quality cataract surgery and efficient resolution of compli...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ophthalmology
سال: 2019
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2019.03.034